Friday 10 January 2014
Antibiotic resistance & making medicines in Britain
The new Director of the Wellcome Trust, Jeremy Farrar is right to highlight the ticking bomb of antibiotic resistance and reminds us of the perils that we face if we continue to ignore this emerging public health issue (Britain is reaching 'a tipping point in its use of antibiotics', Jan 8). Part of the solution must inevitably involve greater working in partnership between commercial organisations such as biotech, pharmaceutical companies, charities, the NHS and central government. But making new medicines is an expensive and risky business.
Subscribe to:
Posts (Atom)
Material progress on Drug Resistant Infections
The O’Neill Review on AntiMicrobial Resistance has led to new initiatives on the development of new diagnostics and drugs along with ...
-
Those of you interested in Higher Education will have read the coalition government's white paper published earlier this year. One recom...
-
I am currently preparing some material for a review on University-Business interactions and I would like to gather as much opinion as possib...
-
David Cameron has come in for some criticism of his idea of a Big Society. Detractors claim that the concept lacks detail and is a tactic ...